Email a Friend
Print ArticleOsteoporosis Health Center
Vitamin K: No Help for Bone Density
Oct. 14, 2008 -- Though often touted as a way to strengthen bones, taking vitamin K for osteopenia does not protect postmenopausal women from age-related declines in bone density, a new study shows.
But it may help them avoid fractures or cancers.
The findings relating to fracture and cancer avoidance were "unexpected," says Angela Cheung, MD, of Toronto's University Health Network and lead author of the study. "It is intriguing and gives us reason for additional research."
The study, published in the journal PLoS Medicine, involved 440 postmenopausal women diagnosed with osteopenia, a "warning" condition of bone loss that can be a precursor to osteoporosis. The disease causes bones to become more fragile and likely to break.
Cheung says the women were either given a vitamin K supplement or a placebo for two years, with 261 continuing for two more years.
"Bone density scans after two years and after four years revealed there were no differences in bone density between the two groups, and that bone density had decreased by similar amounts," Cheung says. "But fewer women over the four-year period had fractures, and fewer had cancer."
Vitamin K and Osteoporosis
Low-dose vitamin K for osteoporosis has been "promoted by the lay media for increasing bone mass" and is widely available in health food stores and over the Internet, according to study researchers.
In Japan, Cheung tells WebMD, vitamin K is an approved treatment for osteoporosis.
But the study researchers say the value of vitamin K to lower risk of bone loss or fractures "remains controversial." The study, whose participants were chosen because they had been diagnosed with osteopenia, concludes that 5 milligrams of vitamin K supplementation daily did not protect them against age-related declines in bone mineral density "at the lumbar spine, total hip, femoral neck, or ultradistal radius" even if they had plenty of vitamin D.
Roberto Pacifici, MD, director of the division of endocrinology at Emory University in Atlanta, says he was unimpressed with the study because it's "been known for some time that there really is no connection between osteoporosis and vitamin K. If you have enough vitamin K deficiency to cause bone weakness, you bleed to death."
He says vitamin D is "very important" for bone strength, but that "people should not go out and buy vitamin K because of this study."
Although Cheung says it would be premature to recommend vitamin K for osteoporosis, she believes it deserves further study in larger groups of women.
About 10 million Americans, 80% of them women, have been diagnosed with osteoporosis; another 34 million people in the U.S. are at risk, according to the National Osteoporosis Foundation.
Previous research suggesting vitamin K supplements might strengthen bones may have had "design and methodological" flaws, Cheung says.
Women in the study did develop fewer fractures, a finding that Cheung says she could not explain and needed further research. Over the four years, nine women had fractures among those taking vitamin K supplements, vs. 20 in the placebo group.
del.icio.us
VIVELLE-DOT (estradiol transdermal system) IS AVAILABLE BY PRESCRPTION ONLY.
INDICATION
Vivelle-Dot is used after menopause to: reduce moderate to severe hot flashes; treat moderate to severe dryness, itching and burning in or around the vagina; help reduce your chances of getting osteoporosis (thin weak bones); and treat certain conditions in which a young woman's ovaries do not produce enough estrogens naturally. Vivelle-Dot 0.025 mg/day is only used to prevent osteoporosis from menopause. If you use Vivelle-Dot only to treat your dryness, itching, and burning in and around your vagina or if you use Vivelle-Dot only to prevent osteoporosis from menopause, talk with your healthcare professional about whether a different treatment or medicine without estrogens might be better for you.
IMPORTANT SAFETY INFORMATION
Estrogens increase the chances of getting cancer of the uterus (womb). Report any unusual vaginal bleeding right away while you are taking estrogens. Vaginal bleeding after menopause may be a warning sign of cancer of the uterus (womb).
Do not use estrogens with or without progestins to prevent heart disease, heart attacks, or strokes. Using estrogens with or without progestins may increase your chances of getting heart attacks, strokes, breast cancer, and blood clots. Using estrogens with progestins may increase your risk of dementia (decline in memory and thinking skills).
Vivelle-Dot should not be used if you have unusual vaginal bleeding; currently have or have had certain cancers, including cancer of the breast or uterus; had a stroke or heart attack in the recent past (for example, in the past year); currently have or have had blood clots; currently have or have had liver problems; or think you may be, or know that you are, pregnant.
The most common side effects that may occur with Vivelle-Dot are headache, breast tenderness, and back pain.
You and your healthcare professional should talk regularly about whether you still need treatment with Vivelle-Dot.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
Please see Full Prescribing Information for Vivelle-Dot.
Taking Vitamin D and Calcium Together
Osteoporosis specialist Dr. Ethel Siris on why it's so important to take calcium with Vitamin D.
